PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Karim Fizazi, MD, PhD - The Science and the Art of Modern Prostate Cancer Care: Improving Patient Outcomes Through Intensification and Individualisation of Treatment
Visit https://www.peervoice.com/HHV860 to view the entire programme with slides. After completing “Karim Fizazi, MD, PhD - The Science and the Art of Modern Prostate Cancer Care: Improving Patient Outcomes Through Intensification and Individualisation of Treatment”, participants will be able to: Evaluate the evolving role of androgen receptor pathway inhibitors (ARPIs) in the modern management of metastatic hormone-sensitive prostate cancer (mHSPC) and nonmetastatic castration-resistant prostate cancer (nmCRPC), according to latest clinical-trial and real-world evidence; Differentiate the ARPIs based upon their characteristics, clinical evidence, and safety profiles; and Propose optimal individualised treatment plans for patients with mHSPC and nmCRPC based on patient- and therapy-specific considerations.